BIRC5 and pancreatic neoplasm: It can also downregulate the EGFR/STAT3/cyclin-D1/survivin and NF-κB/IκBα/cyclin-D1/survivin pathways, leading to apoptosis in pancreatic cancer cells (PANC-1) [91].